Php120 - What Do We Stand to Lose? The Proportion of Us-Owned Pharmaceuticals on Australia’s Pharmaceutical Benefits Scheme

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Correction To: What Do We Lose When Machines Take the Decisions?

Journal of Management and Governance
International ManagementBusiness
2020English

The Dinosaur in the Classroom: What We Stand to Lose Through Ability-Grouping in the Primary School

FORUM
2014English

Monolithy, Multiplicity, or Multivocality: What Do We Stand for and Where Do We Go From Here?

Journal of Learning Analytics
Computer Science ApplicationsEducation
2019English

Men?s Health: Where Do We Stand and What Lies Ahead?

Andrology-Open Access
2015English

Distributional Impact of Higher Patient Contributions to Australia's Pharmaceutical Benefits Scheme

Australian Health Review
Health Policy
2000English

Traffic: Why We Drive the Way We Do (And What It Says About Us)

2009English

“You Keep Telling Us Different Things, What Do We Believe?”

Pragmatics and Society
LinguisticsLanguage
2019English

Why We Do What We Do

Journal of Parenteral and Enteral Nutrition
MedicineNutritionDietetics
2008English

We (Do Not) Stand on Guard for Thee

CMAJ
Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy